Ramipril
In the US, Ramipril (ramipril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.
US matches:
UK matches:
- RAMIPRIL 1.25 MG CAPSULES (Leaflet)
- RAMIPRIL 1.25 MG TABLETS (Leaflet)
- RAMIPRIL 1.25MG CAPSULES (Leaflet)
- RAMIPRIL 1.25MG CAPSULES HARD (Leaflet)
- RAMIPRIL 1.25MG TABLETS (Leaflet)
- RAMIPRIL 10 MG CAPSULES (Leaflet)
- RAMIPRIL 10 MG TABLETS (Leaflet)
- RAMIPRIL 10MG CAPSULES (Leaflet)
- RAMIPRIL 10MG CAPSULES HARD (Leaflet)
- RAMIPRIL 10MG TABLETS (Leaflet)
- RAMIPRIL 2.5 MG CAPSULES (Leaflet)
- RAMIPRIL 2.5 MG TABLETS (Leaflet)
- RAMIPRIL 2.5MG CAPSULES (Leaflet)
- RAMIPRIL 2.5MG CAPSULES HARD (Leaflet)
- RAMIPRIL 2.5MG TABLETS (Leaflet)
- RAMIPRIL 2.5MG/5ML ORAL SOLUTION (Leaflet)
- RAMIPRIL 5 MG CAPSULES (Leaflet)
- RAMIPRIL 5 MG TABLETS (Leaflet)
- RAMIPRIL 5MG CAPSULES (Leaflet)
- RAMIPRIL 5MG CAPSULES HARD (Leaflet)
- RAMIPRIL 5MG TABLETS (Leaflet)
Ingredient matches for Ramipril
Ramipril (BAN, DCF, USAN) is known as Ramipril in the US.
Hydrochlorothiazide is reported as an ingredient of Ramipril in the following countries:
- Israel
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
